MSB 2.23% $1.10 mesoblast limited

2024 Here we go again., page-287

  1. 12,198 Posts.
    lightbulb Created with Sketch. 1084
    His face to face meeting was attended in person by the company (Dr Itescu and others) and Dr. Nicole Verdun – being the newly appointed permanent Director of the FDA’s Centre for Biologics Evaluation and Research Office Of Therapeutic Products. The presence of senior leadership from the FDA is an encouraging sign of the intent of the Agency to facilitate an approval for Remestemcel-L

    Well Col the way I see it is a deal was made over the Table with the Boss.
    In that meeting the Blood and Marrow delegation was present.
    SI says he has keep his side of the bargain.

    33.5 c

    Lets see.

    Aloha.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.10
Change
-0.025(2.23%)
Mkt cap ! $1.250B
Open High Low Value Volume
$1.13 $1.16 $1.04 $14.57M 13.49M

Buyers (Bids)

No. Vol. Price($)
4 21024 $1.09
 

Sellers (Offers)

Price($) Vol. No.
$1.10 241 1
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.